1. AI identifies potential drugs and a DNA vaccine in the works — latest on Covid-19  ThePrint
  2. 35 companies in race to produce wonder vaccine to prevent COVID-19, trials started  Times of India
  3. Potential COVID-19 therapeutics currently in development  European Pharmaceutical Review
  4. Coronavirus vaccine: how soon will we have one?  World Economic Forum
  5. Covid-19 vaccine availability unrealistic in 12-18 month period  Pharmaceutical Technology
  6. View Full coverage on Google News
The infection may cause cardiac injury but is unlikely to spread through tears. ThePrint brings you top 5 developments on the coronavirus front across the world.The infection may cause cardiac injury but is unlikely to spread through tears. ThePrint brings you top 5 developments on the coronavirus front across the world.

AI identifies potential drugs and a DNA vaccine in the works — latest on Covid-19

The infection may cause cardiac injury but is unlikely to spread through tears. ThePrint brings you top 5 developments on the coronavirus front across the world.The infection may cause cardiac injury but is unlikely to spread through tears. ThePrint brings you top 5 developments on the coronavirus front across the world.

AI identifies potential drugs and a DNA vaccine in the works — latest on Covid-19

India News: Around 35 pharmaceutical companies and institutes are racing against time to create a possible vaccine to prevent thousands of people getting infectedIndia News: Around 35 pharmaceutical companies and institutes are racing against time to create a possible vaccine to prevent thousands of people getting infected

35 companies in race to produce wonder vaccine to prevent COVID-19, trials started | India News - Times of India

As the world rushes to identify the best coronavirus treatments, John Cahill rounds up the latest developments in potential COVID-19 therapies.As the world rushes to identify the best coronavirus treatments, John Cahill rounds up the latest developments in potential COVID-19 therapies.

Potential COVID-19 therapeutics currently in development

The race is on to find a vaccine for COVID-19, but the process is complex and expensive. Here's what to know about how they're made and how long it takes. The race is on to find a vaccine for COVID-19, but the process is complex and expensive. Here's what to know about how they're made and how long it takes.

Coronavirus vaccine: how soon will we have one? | World Economic Forum

Researchers are being given a boost on everything from fast regulations to sequencing of virus genomeResearchers are being given a boost on everything from fast regulations to sequencing of virus genome

Coronavirus: Unprecedented political will could bring a quick vaccine in months | inews

“Question: What will be alternative scenario for Tokyo in spring/summer 2021 if then no vaccine/efficient therapy for Corona existing? To act responsibly now would mean to admit publicly that nobody can guarantee safe date in 2021. Or does IOC want to sideline critics again?”

Hajo Seppelt on Twitter: "Question: What will be alternative scenario for Tokyo in spring/summer 2021 if then no vaccine/efficient therapy for Corona existing? To act responsibly now would mean to admit publicly that nobody can guarantee safe date in 2021. Or does IOC want to sideline critics again?"

“I am happy to know that @IITGuwahati is exploring the possibilities to clone the immunogenic proteins of SARS-CoV-2 which can be used for diagnosis as well as to produce vaccine for novel coronavirus infected patients. #IndiaFightsCorona https://t.co/V8TY9IcyiB”

Dr Ramesh Pokhriyal Nishank on Twitter: "I am happy to know that @IITGuwahati is exploring the possibilities to clone the immunogenic proteins of SARS-CoV-2 which can be used for diagnosis as well as to produce vaccine for novel coronavirus infected patients. #IndiaFightsCorona https://t.co/V8TY9IcyiB"

“Akers Biosciences acquires licenses to Corona Virus Vaccine Candidate from Premas Biotech. It’s under development and the host is Genetically engineered yeast. @prabuddha_kundu https://t.co/fNG5rbqt6C”

Riteish Deshmukh on Twitter: "Akers Biosciences acquires licenses to Corona Virus Vaccine Candidate from Premas Biotech. It’s under development and the host is Genetically engineered yeast. @prabuddha_kundu https://t.co/fNG5rbqt6C"

“Can someone please explain the conspiracy theory that the coronavirus was created just to enforce mandatory vaccinations on all of us? Like, the evil plan is to make us all take vaccines that eradicate disease? Worst evil plot ever tbh.”

Jason Howerton on Twitter: "Can someone please explain the conspiracy theory that the coronavirus was created just to enforce mandatory vaccinations on all of us? Like, the evil plan is to make us all take vaccines that eradicate disease? Worst evil plot ever tbh."

The 12–18-month timeline often touted for Covid-19 vaccine availability is unrealistic, experts said, estimating 18–24 months instead.The 12–18-month timeline often touted for Covid-19 vaccine availability is unrealistic, experts said, estimating 18–24 months instead.

Covid-19 vaccine availability unrealistic in 12-18 month period

Womansera magazine is a platform for women to get latest info and tips on fashion, beauty, health and relationship advice. Subscribe to India's No.1 women's magazine!Womansera magazine is a platform for women to get latest info and tips on fashion, beauty, health and relationship advice. Subscribe to India's No.1 women's magazine!

Coronavirus Vaccine: How Soon Will We Have One? -

Scientists around the world are studying the coronavirus, its effects, and how to stop it.Scientists around the world are studying the coronavirus, its effects, and how to stop it.

Virus science — a look at coronavirus research around the globe - National | Globalnews.ca

NoCookies | The Australian

Dr Peter Smith, from the London School of Hygiene and Tropical Medicine, said a unique approach could 'shave months' off vaccine development.Dr Peter Smith, from the London School of Hygiene and Tropical Medicine, said a unique approach could 'shave months' off vaccine development.

Volunteers should be infected with the coronavirus to speed up vaccine, researchers say | Daily Mail Online

Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics and hybrid viruses. It is likely a mix of these approaches will be used to fight the coronavirus.Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics and hybrid viruses. It is likely a mix of these approaches will be used to fight the coronavirus.

Labs are experimenting with new – but unproven – methods to create a coronavirus vaccine fast

Labs are experimenting with new – but unproven – methods to create a coronavirus vaccine fast

‘No Shortcuts’: Coronavirus Vaccine Developed by Cambridge-Based Company Begins Phase One of Testing | News | The Harvard Crimson

A video of US President Donald Trump and a top US pharmaceutical executive speaking at a press conference has been viewed thousands of times in multiple Facebook, Twitter and YouTube posts alongside a claim that it shows them announcing a vaccine for the novel coronavirus, COVID-19, was "ready" to be administered. The claim is false; neither Trump nor the pharmaceuticalA video of US President Donald Trump and a top US pharmaceutical executive speaking at a press conference has been viewed thousands of times in multiple Facebook, Twitter and YouTube posts alongside a claim that it shows them announcing a vaccine for the novel coronavirus, COVID-19, was "ready" to be administered. The claim is false; neither Trump nor the pharmaceutical executive make any reference to a vaccine being "ready" for distribution; as of March 2020, the World Health Organization (WHO) states there is not yet a vaccine for COVID-19.

US President Donald Trump did not announce a coronavirus vaccine was 'ready' | AFP Fact Check

‘It could be ready in 12 to 18 months. That is great if it happens’‘It could be ready in 12 to 18 months. That is great if it happens’

The science behind the race to develop a coronavirus vaccine